EcoDrugPlus

Activin A Receptor Type 2b

Ensembl ID : ENSDLEG00000012051
Gene Symbol: ACVR2B
1 Cross references
259 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSDLEG00000006076
Gene Symbol: ADORA1
3 Cross references
275 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSDLEG00000016554
Gene Symbol: ADORA2A
3 Cross references
264 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSDLEG00000020932
Gene Symbol: ADORA2B
3 Cross references
201 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSDLEG00000014971
Gene Symbol: ADORA3
3 Cross references
273 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSDLEG00000002282
Gene Symbol: ADA
3 Cross references
219 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSDLEG00000007029
Gene Symbol: ADRM1
3 Cross references
261 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSDLEG00000001167
Gene Symbol: ADRA1A
3 Cross references
201 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSDLEG00000011733
Gene Symbol: ADRA1B
3 Cross references
265 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSDLEG00000000185
Gene Symbol: ADRA1D
3 Cross references
196 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSDLEG00000012016
Gene Symbol: ADRA2A
3 Cross references
227 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSDLEG00000003683
Gene Symbol: ADRA2B
3 Cross references
222 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).